Gottlieb is a senior fellow at the American Enterprise Institute and former FDA commissioner. McClellan is director of the Duke Margolis Institute for Health Policy and former FDA commissioner and ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Infectious diseases pose complex biological and public health challenges that demand innovative scientific solutions. Researchers now employ diverse approaches to study pathogen biology, examine ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. It's been more than 10 years since the 2014 Ebola epidemic, when the often-fatal viral infection ...

Two emerging pathogens with animal origins—influenza D virus and canine coronavirus—have so far been quietly flying under the radar, but researchers warn conditions are ripe for the viruses to spread ...

Throughout human history, disease outbreaks have emerged and re-emerged. What’s different now is that with global travel, outbreaks can move quickly among and between populations. A familiar example ...

Measles made headlines last year and it's not stopping so far in 2026. It's one of five infectious diseases that doctors say we should keep an eye on this year. Emerging and re-emerging infectious ...

Many emerging and re-emerging infectious diseases, especially zoonotic diseases such as ebola or new coronaviruses, emerge as the result of intensified human activities such as deforestation, ...

A new review study traces the complex links between biodiversity loss and emerging infectious diseases — though one doesn’t necessarily lead to the other. Instead, complex interactions between factors ...